Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kuniko Mizuta is active.

Publication


Featured researches published by Kuniko Mizuta.


American Journal of Human Genetics | 2010

Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies

V. Bolduc; Gareth Marlow; Kym M. Boycott; Khalil Saleki; Hiroshi Inoue; Johan T. M. Kroon; Mitsuo Itakura; Yves Robitaille; Lucie Parent; Frank Baas; Kuniko Mizuta; Nobuyuki Kamata; Isabelle Richard; W. H. J. P. Linssen; Ibrahim Mahjneh; Marianne de Visser; Rumaisa Bashir; Bernard Brais

The recently described human anion channel Anoctamin (ANO) protein family comprises at least ten members, many of which have been shown to correspond to calcium-activated chloride channels. To date, the only reported human mutations in this family of genes are dominant mutations in ANO5 (TMEM16E, GDD1) in the rare skeletal disorder gnathodiaphyseal dysplasia. We have identified recessive mutations in ANO5 that result in a proximal limb-girdle muscular dystrophy (LGMD2L) in three French Canadian families and in a distal non-dysferlin Miyoshi myopathy (MMD3) in Dutch and Finnish families. These mutations consist of a splice site, one base pair duplication shared by French Canadian and Dutch cases, and two missense mutations. The splice site and the duplication mutations introduce premature-termination codons and consequently trigger nonsense-mediated mRNA decay, suggesting an underlining loss-of-function mechanism. The LGMD2L phenotype is characterized by proximal weakness, with prominent asymmetrical quadriceps femoris and biceps brachii atrophy. The MMD3 phenotype is associated with distal weakness, of calf muscles in particular. With the use of electron microscopy, multifocal sarcolemmal lesions were observed in both phenotypes. The phenotypic heterogeneity associated with ANO5 mutations is reminiscent of that observed with Dysferlin (DYSF) mutations that can cause both LGMD2B and Miyoshi myopathy (MMD1). In one MMD3-affected individual, defective membrane repair was documented on fibroblasts by membrane-resealing ability assays, as observed in dysferlinopathies. Though the function of the ANO5 protein is still unknown, its putative calcium-activated chloride channel function may lead to important insights into the role of deficient skeletal muscle membrane repair in muscular dystrophies.


Journal of Cellular Physiology | 2014

TMEM16E (GDD1) Exhibits Protein Instability and Distinct Characteristics in Chloride Channel/Pore Forming Ability

Ta To Tran; Kei Tobiume; Chikara Hirono; Shinichi Fujimoto; Kuniko Mizuta; Kazumi Kubozono; Hiroshi Inoue; Mitsuo Itakura; Makoto Sugita; Nobuyuki Kamata

TMEM16E/GDD1 has been shown to be responsible for the bone‐related late‐onset disease gnathodiaphyseal dysplasia (GDD), with the dominant allele (TMEM16Egdd) encoding a missense mutation at Cys356. Additionally, several recessive loss‐of‐function alleles of TMEM16E also cause late‐onset limb girdle muscular dystrophy. In this study, we found that TMEM16E was rapidly degraded via the proteasome pathway, which was rescued by inhibition of the PI3K pathway and by the chemical chaperone, sodium butyrate. Moreover, TMEM16Egdd exhibited lower stability than TMEM16E, but showed similar propensity to be rescued. TMEM16E did not exhibit cell surface calcium‐dependent chloride channel (CaCC) activity, which was originally identified in TMEM16A and TMEM16B, due to their intracellular vesicle distribution. A putative pore‐forming domain of TMEM16E, which shared 39.8% similarity in 98 amino acids with TMEM16A, disrupted CaCC activity of TMEM16A via domain swapping. However, the Thr611Cys mutation in the swapped domain, which mimicked conserved cysteine residues between TMEM16A and TMEM16B, reconstituted CaCC activity. In addition, the GDD‐causing cysteine mutation made in TMEM16A drastically altered CaCC activity. Based on these findings, TMEM16E possesses distinct function other than CaCC and another protein‐stabilizing machinery toward the TMEM16E and TMEM16Egdd proteins should be considered for the on‐set regulation of their phenotypes in tissues. J. Cell. Physiol. 229: 181–190, 2014.


Diabetes Research and Clinical Practice | 2008

Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic β-cells prevents progression of diabetes in db/db mice

Katsuyuki Miyawaki; Hiroshi Inoue; Parvaneh Keshavarz; Kuniko Mizuta; Aya Sato; Yukiko Sakamoto; Maki Moritani; Kiyoshi Kunika; Toshihito Tanahashi; Mitsuo Itakura

In an attempt to rectify the hyperglycemic state in obese insulin resistant db/db mice, a transgenic line was generated (db/db-CDK4(R24C)) that expresses a constitutively active form of cyclin-dependent kinase 4 (CDK4/R24C) under the control of the insulin promoter. Compared with non-transgenic db/db littermates, adult db/db-CDK4(R24C) mice show near-complete glycemic normalization and improved plasma lipid concentrations, but are also more susceptible to weight gain and have significantly lower plasma adiponection levels. They have striking islet hypertrophy and beta-cell hyperplasia, and retain an insulin secretory response during the glucose tolerance test. We examined the expression of several key regulatory transcription factor genes involved in lipid and glucose metabolism in insulin target tissues of db/db-CDK4(R24C) as well as db/db mice, and found that the expression levels of members of the peroxisome proliferator-activated receptor (PPAR) family are highly associated with metabolic alterations in a gene- and tissue-specific manner. We show for the first time that the Ppar-delta in skeletal muscle and white adipose tissues is transcriptionally down-regulated in db/db mice. The db/db-CDK4(R24C) mice present a novel model of leptin-resistant obesity with compensatory hyperinsulinemia and normalized blood glucose levels, and thus may be useful for future studies that aim to dissect relationships between insulin and leptin signaling.


Head & Face Medicine | 2013

Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature

Kouji Ohta; Masayuki Taki; Ikuko Ogawa; Shigehiro Ono; Kuniko Mizuta; Shinichi Fujimoto; Takashi Takata; Nobuyuki Kamata

Ossifying fibromyxoid tumor (OFMT) is a rare mesenchymal neoplasm that arises in subcutaneous tissue, with that in the oral cavity extremely rare. We present a case of malignant OFMT in the tongue. A 26-year-old male noticed a painless mass in the tongue, which was extracted at a general hospital. Four years later, the tumor recurred and was resected at our department. Histologically, the recurrent tumor was composed of the closely packed cells positive for vimentin and S-100 proliferating in a nodular fashion. It showed high cellularity and mitotic activity. In the primary tumor, some tumor cells were arranged in a diffuse or cord-like manner within an abundant fibromyxoid matrix, along with a small amount of metaplastic ossification, corresponding with the histopathological characteristic of OFMT. Accordingly, a diagnosis of malignant OFMT arising in typical OFMT was established. This is the first reported case of malignant OFMT in the tongue. Long-term follow-up is needed for confirmation of prognosis and biological behavior.


Journal of Dental Research | 2009

Amphiregulin Induces Proliferative Activities in Osseous Dysplasia

Hideo Shigeishi; S. Yamaguchi; Kuniko Mizuta; Koichi Nakakuki; Shinichi Fujimoto; Teruo Amagasa; Nobuyuki Kamata

Human osseous dysplasia (OD) is a benign fibro-osseous neoplasm of periodontal ligament origin in which normal bone is replaced with fibrous connective tissue containing abnormal bone or cementum. However, cellular differentiation and proliferation in OD have not been fully elucidated. In vitro culture systems have distinct advantages for analytical studies. Therefore, we established immortalized cell lines (OD-1) from OD lesions of the jaw from an individual with gnathodiaphyseal dysplasia (GDD). We hypothesized that OD-1 had a characteristic growth mechanism different from that of mineralized-associated cells such as osteoblasts. To clarify the difference of gene expression patterns between OD-1 and osteoblasts, we compared the profiles of genes expressed in the 2 cell types by microarray analysis. We identified amphiregulin to be highly expressed in OD-1 compared with osteoblasts and gingival fibroblasts. OD-1 showed proliferative activities regulated in an autocrine manner by amphiregulin, and amphiregulin may play a significant role in the proliferation of OD.


Biochemical and Biophysical Research Communications | 2006

Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells.

Yukiko Sakamoto; Hiroshi Inoue; Shuhei Kawakami; Katsuyuki Miyawaki; Tatsuro Miyamoto; Kuniko Mizuta; Mitsuo Itakura


Biochemical and Biophysical Research Communications | 2007

Molecular characterization of GDD1/TMEM16E, the gene product responsible for autosomal dominant gnathodiaphyseal dysplasia

Kuniko Mizuta; Satoshi Tsutsumi; Hiroshi Inoue; Yukiko Sakamoto; Katsutoshi Miyatake; Katsuyuki Miyawaki; Sumihare Noji; Nobuyuki Kamata; Mitsuo Itakura


Biochemical and Biophysical Research Communications | 2005

Molecular cloning and characterization of the murine gnathodiaphyseal dysplasia gene GDD1.

Satoshi Tsutsumi; Hiroshi Inoue; Yukiko Sakamoto; Kuniko Mizuta; Nobuyuki Kamata; Mitsuo Itakura


Oral Oncology | 2005

Correlation of CENP-F gene expression with tumor-proliferating activity in human salivary gland tumors

Hideo Shigeishi; Kuniko Mizuta; Koichiro Higashikawa; Shingo Yoneda; Shigehiro Ono; Nobuyuki Kamata


Oncology Reports | 2006

Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity

Hideo Shigeishi; Koichiro Higashikawa; Shigehiro Ono; Kuniko Mizuta; Yoshiaki Ninomiya; Shingo Yoneda; Masayuki Taki; Nobuyuki Kamata

Collaboration


Dive into the Kuniko Mizuta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge